TY - JOUR
T1 - Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies
AU - Eraña, Hasier
AU - Charco, Jorge M
AU - Di Bari, Michele A
AU - Díaz-Domínguez, Carlos M
AU - López-Moreno, Rafael
AU - Vidal, Enric
AU - González-Miranda, Ezequiel
AU - Pérez-Castro, Miguel A
AU - García-Martínez, Sandra
AU - Bravo, Susana
AU - Fernández-Borges, Natalia
AU - Geijo, Mariví
AU - D'Agostino, Claudia
AU - Garrido, Joseba
AU - Bian, Jifeng
AU - König, Anna
AU - Uluca-Yazgi, Boran
AU - Sabate, Raimon
AU - Khaychuk, Vadim
AU - Vanni, Ilaria
AU - Telling, Glenn C
AU - Heise, Henrike
AU - Nonno, Romolo
AU - Requena, Jesús R
AU - Castilla, Joaquín
PY - 2019/10
Y1 - 2019/10
N2 - The resolution of the three-dimensional structure of infectious prions at the atomic level is pivotal to understand the pathobiology of Transmissible Spongiform Encephalopathies (TSE), but has been long hindered due to certain particularities of these proteinaceous pathogens. Difficulties related to their purification from brain homogenates of disease-affected animals were resolved almost a decade ago by the development of in vitro recombinant prion propagation systems giving rise to highly infectious recombinant prions. However, lack of knowledge about the molecular mechanisms of the misfolding event and the complexity of systems such as the Protein Misfolding Cyclic Amplification (PMCA), have limited generating the large amounts of homogeneous recombinant prion preparations required for high-resolution techniques such as solid state Nuclear Magnetic Resonance (ssNMR) imaging. Herein, we present a novel recombinant prion propagation system based on PMCA that substitutes sonication with shaking thereby allowing the production of unprecedented amounts of multi-labeled, infectious recombinant prions. The use of specific cofactors, such as dextran sulfate, limit the structural heterogeneity of the in vitro propagated prions and makes possible, for the first time, the generation of infectious and likely homogeneous samples in sufficient quantities for studies with high-resolution structural techniques as demonstrated by the preliminary ssNMR spectrum presented here. Overall, we consider that this new method named Protein Misfolding Shaking Amplification (PMSA), opens new avenues to finally elucidate the three-dimensional structure of infectious prions.
AB - The resolution of the three-dimensional structure of infectious prions at the atomic level is pivotal to understand the pathobiology of Transmissible Spongiform Encephalopathies (TSE), but has been long hindered due to certain particularities of these proteinaceous pathogens. Difficulties related to their purification from brain homogenates of disease-affected animals were resolved almost a decade ago by the development of in vitro recombinant prion propagation systems giving rise to highly infectious recombinant prions. However, lack of knowledge about the molecular mechanisms of the misfolding event and the complexity of systems such as the Protein Misfolding Cyclic Amplification (PMCA), have limited generating the large amounts of homogeneous recombinant prion preparations required for high-resolution techniques such as solid state Nuclear Magnetic Resonance (ssNMR) imaging. Herein, we present a novel recombinant prion propagation system based on PMCA that substitutes sonication with shaking thereby allowing the production of unprecedented amounts of multi-labeled, infectious recombinant prions. The use of specific cofactors, such as dextran sulfate, limit the structural heterogeneity of the in vitro propagated prions and makes possible, for the first time, the generation of infectious and likely homogeneous samples in sufficient quantities for studies with high-resolution structural techniques as demonstrated by the preliminary ssNMR spectrum presented here. Overall, we consider that this new method named Protein Misfolding Shaking Amplification (PMSA), opens new avenues to finally elucidate the three-dimensional structure of infectious prions.
KW - Animals
KW - Arvicolinae
KW - Central Nervous System/pathology
KW - Dextran Sulfate/pharmacology
KW - Disease Models, Animal
KW - Mice, Transgenic
KW - Nuclear Magnetic Resonance, Biomolecular/methods
KW - Prion Diseases/pathology
KW - Prion Proteins/metabolism
KW - Prions/metabolism
KW - Protein Structure, Tertiary
KW - Proteostasis Deficiencies/pathology
U2 - 10.1371/journal.ppat.1008117
DO - 10.1371/journal.ppat.1008117
M3 - Article
C2 - 31644574
VL - 15
SP - e1008117
JO - PLoS Pathogens
JF - PLoS Pathogens
SN - 1553-7366
IS - 10
ER -